Industry symposia

Our industry supporters will once again be offering you an outstanding programme of sessions to complement your attendance at Rheumatology 2010. These symposia, featuring exciting speakers and innovative formats continue to be an essential part of the delegate experience.

Currently booked to run sessions are:

Provisional programmes (last updated 15 December 2009):
 
Tuesday 20 April 2010                            20.00 - 21.30

Wednesday 21 April 2010                       18.00 – 19.30 

Abbott

Scientific Objectives:
• Discuss the rationale for early treatment, giving practical guidance on making steps to achieve it
• Demonstrate the benefits to patients of achieving early, intensive treatment with biologics in a real life clinical setting.
• Explore how early treatment with biological therapies can be achieved within the current guidelines and infrastructure
• Consider the benefits of treating patients with a DAS>3.2 with biologics, highlighting the potential clinical implications and how this may be achieved and the resources required

Chairman: Paul Emery

Welcome and introduction Paul Emery
Achieving the transition to early treatment Andrew Ostor
Real life patient outcomes Tricia Cornell
How “tight” to TICORA can we achieve in clinical practice? Duncan Porter
Interactive panel discussion

Roche (Roactemra)
Programme tbc

Thursday 22 April 2010                          18.00 – 19.30 

Roche (Mabthera)
Programme tbc

UCB Pharmaceuticals

A patient-focused approach to the management of rheumatoid arthritis

A patient-led model of care: what is the patient with RA really looking for? Ailsa Bosworth (NRAS)
Treating RA: the benefits and challenges of new and emerging treatments Peter Taylor
Spotlight on RA management: the commissioning perspective Craig Black
Meeting the needs of patients with RA in the real world Anthony Hammond
Case study led by Peter Taylor (to integrate all aspects of delivering treatment to the patient)

Friday 23 April 2010                              07.30 – 09.00 

Actelion

Question Time: Is early referral for PAH the way forward for systemic sclerosis (SSc)?
Actelion would like to invite you to attend a unique session of scientific discussion and debate. The panel will include experts from around the UK and will be facilitated by leading journalist Jon Snow. Please join us for what will be an interesting and informative meeting.

Meeting chair: Jon Snow, presenter of Channel 4 news
Meeting co-chair: tbc
Panel: tbc

Welcome breakfast
Welcome and introduction of the panel Jon Snow

Presentation: Pulmonary arterial hypertension in SSc – the UK experience

Meeting facilitator to run session of open discussion and debate
Topics to be discussed with the panel:

• Screening – how do you manage high risk patients?
• What do specialist PAH centers offer?
• Why refer to a specialist PAH center?
• What difference does early referral and treatment really make?

Audience Q & A
Summary and close 

Amgen

Evidence Bulletins in the Management of Osteoporosis

Falls and Fracture Prevention strategies for Healthy Aging
UK Primary Care Data measuring compliance and persistence in Osteoporosis
Emerging clinical data in preventing fractures